On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults.
All posts by admin
Perfect Bar & Company Recalls Peanut Butter and Cranberry Crunch Nutrition Bars Due to Possible Health Risk
After Perfect Bar’s routine product testing, the company is issuing a nationwide recall of specific lot numbers of its Peanut Butter and Cranberry Crunch flavor recipes due to potential contamination of Salmonella. While no illnesses to date have been associated with any of the recalled products,
Salmonella bacteria can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
Kkot Saem Sprouts, Inc. Recalls Soybean Sprouts and Mungbean Sprouts Because of Possible Health Risk
Kkot Saem Sprouts, Inc. of Spanaway, Washington is voluntarily recalling Soybean Sprouts and Mungbean Sprouts sold under brand names Kkot Saem, Winter Blossom Bean Sprouts, and Winter Blossom because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, listeria infection can cause miscarriages and stillbirths among pregnant women.
Bethel Nutritional Consulting, Inc. Issues Nationwide Voluntary Recall of SLIM-K Capsules Due to Undeclared Drug Ingredients
Bethel Nutritional Consulting, Inc. is recalling one lot of SLIM-K Capsules to the consumer level. The firm was informed by the US Food and Drug Administration (FDA) that a sample of SLIM-K collected and tested by the FDA was found to contain Sibutramine, desmethylsibutramine, and Phenolphthalein.
Bethel Nutritional Consulting, Inc. Issues Nationwide Voluntary Recall of B-Lipo Capsules Due to the Presence of an Undeclared Drug Ingredient
Bethel Nutritional Consulting, Inc. is recalling one lot of B-Lipo Capsules to the consumer level. The firm was informed by the US Food and Drug Administration (FDA) that a sample of B-Lipo Capsules collected and tested by the FDA was found to contain Lorcaserin, a controlled substance used for weight loss.
FDA approves new antibacterial drug Zerbaxa
The U.S. Food and Drug Administration today approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI).
FDA approves new antibacterial drug Zerbaxa
The U.S. Food and Drug Administration today approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI).
Reily Foods Recalls Chili Seasoning Kits Due to Undeclared Peanut and Almond Allergens
Reily Foods Co., New Orleans, announced today it is recalling certain Carroll Shelby brand and Wick Fowler brand chili seasoning kits after learning that one or more of the spice ingredients purchased from a third-party supplier contain peanut and almond allergens that are not declared on the products’ ingredient statements. People who have an allergy or severe sensitivity to peanuts and almonds run the risk of serious or life-threatening allergic reaction if they consume these products.
FDA approves Viekira Pak to treat hepatitis C
The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.
FDA approves Viekira Pak to treat hepatitis C
The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.